Prospective, randomized phase III study comparing two intensified regimens (methotrexate/vinblastine/doxorubicin hydrochloride/cisplatin MVAC versus gemcitabine/cisplatin) in patients with inoperable or recurrent urothelial cancer

Auteur

Bamias, A.; Karadimou, A.; Lampaki, S.; Aravantinos, G.; Xanthakis, I.; Papandreou, C.; Lainakis, G.; Zagouri, F.; Soupos, N.; Kostouros, E.; Samantas, E.; Hatzimouratidis, C.; Konstantinidis, C.; Deliveliotis, C.; Pectasides, D. G.; Fountzilas, G.; Dimopoulos, M. A.; Hellenic Cooperative Oncology, Grp

Date

2011

Sujet

Oncology

Afficher la notice complète

URI

http://hdl.handle.net/11615/26136

Collections

• Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19735]